NEW YORK (
) is trading at unusually high volume Friday with 3.3 million shares changing hands. It is currently at 10.8 times its average daily volume and trading down 52 cents (-5.7%) at $8.68 as of 10:11 a.m. ET.
BioMimetic has a market cap of $257.5 million and is part of the
industry. Shares are down 27.6% year to date as of the close of trading on Thursday.
BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage.
TheStreet Ratings rates BioMimetic as a
. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from